Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: Serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum
- 31 October 1993
- journal article
- Published by Elsevier in Contraception
- Vol. 48 (4) , 303-322
- https://doi.org/10.1016/0010-7824(93)90077-k
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Single and multiple administration of a new triphasic oral contraceptive to women: Pharmacokinetics of ethin l estradiol and free and total testosterone levels in serumAmerican Journal of Obstetrics and Gynecology, 1991
- The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrelContraception, 1991
- Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three monthsContraception, 1991
- Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to womenAmerican Journal of Obstetrics and Gynecology, 1990
- Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serumThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Single dose phakmacokinetics of gestodene in women after intravenous and oral administrationContraception, 1989
- Development and application of a radioimmunoassay of the new progestagen gestodeneContraception, 1989
- Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 75 μg gestodeneContraception, 1988
- Distribution and percentages of non-protein bound contraceptive steroids in human serumThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Investigations of pharmacokinetics of ethinyloestradiol to specific consideration of a possible first-pass effect in womenContraception, 1979